Biolase, Inc. (BIOLQ) vs Catheter Precision, Inc. (VTAK)
Biolase, Inc. and Catheter Precision, Inc. are both Medical Devices companies. Catheter Precision, Inc. is the larger, with a market value of $3.0M against $2.3M — 1.3× the size. Catheter Precision, Inc. grew revenue faster over the last twelve months: 219.2% against −7.44%. Biolase, Inc. has the higher net margin (−71.8% vs −711.5%) and the lower return on invested capital (−109.5% vs −64.4%). Across the 16 metrics below, Biolase, Inc. leads on 11 and Catheter Precision, Inc. on 5.
Valuation
Profitability
| Metric | BIOLQ | VTAK | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 47.73% | 56.01% |
| Operating margin | (29.37%) | (1,000.26%) | (15.03%) |
| Net margin | (71.75%) | (711.49%) | (20.40%) |
| Free cash flow margin | (28.55%) | (489.45%) | (7.24%) |
| Return on equity | 1,349.30% | (115.04%) | (15.32%) |
| Return on assets | (100.09%) | (43.65%) | (19.72%) |
| Return on invested capital | (109.48%) | (64.41%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack